Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced that company management ...

Q2 2024 Earnings Call Transcript September 24, 2024 Operator: Good morning, and welcome to the Altamira Therapeutics First ...

Elixirgen Therapeutics is currently enrolling patients in its Phase 1/2 trial evaluating EXG-34217 in patients with telomere biology disorders at Cincinnati Children’s Hospital Medical CenterBALTIMORE ...

As Americans get ready for fall and winter, the U.S. government is offering another round of free COVID tests, ava ...

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Moderna (MRNA) closed at $63.94 in the latest trading session, marking a -0.31% move from the prior day. This change lagged the S&P 500's 0.25% gain on the day. At the same time, the Dow added 0.2%, ...

Shares of Moderna Inc. MRNA dropped 0.31% to $63.94 Tuesday, on what proved to be an all-around favorable trading session for ...

As levels of the coronavirus have increased in Missouri and across the country, the federal government has approved updated vaccines to protect against COVID-19. The virus itself has changed, and ...

Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies ...

A prominent Florida doctor expressed dismay that medical leaders in the state, leery of angering Gov. Ron DeSantis, have been ...

Buying $100 In MRNA: If an investor had bought $100 of MRNA stock 5 years ago, it would be worth $406.92 today based on a ...